The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody Cixutumumab
about
Preoperative Metabolic Syndrome Is Predictive of Significant Gastric Cancer Mortality after Gastrectomy: The Fujian Prospective Investigation of Cancer (FIESTA) StudyHyperglycaemia Induced by Novel Anticancer Agents: An Undesirable Complication or a Potential Therapeutic Opportunity?Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials.
P2860
The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody Cixutumumab
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Prevalence and Impact of H ...... -Receptor Antibody Cixutumumab
@ast
The Prevalence and Impact of H ...... -Receptor Antibody Cixutumumab
@en
type
label
The Prevalence and Impact of H ...... -Receptor Antibody Cixutumumab
@ast
The Prevalence and Impact of H ...... -Receptor Antibody Cixutumumab
@en
prefLabel
The Prevalence and Impact of H ...... -Receptor Antibody Cixutumumab
@ast
The Prevalence and Impact of H ...... -Receptor Antibody Cixutumumab
@en
P2093
P2860
P1433
P1476
The Prevalence and Impact of H ...... -Receptor Antibody Cixutumumab
@en
P2093
David S Hong
Helen X Chen
Kenneth R Hess
Kristie Lawhorn
Lawrence A Doyle
Mohammed Amir Habra
Naifa L Busaidy
Patricia LoRusso
P2860
P304
P356
10.1634/THEONCOLOGIST.2015-0065
P577
2015-06-08T00:00:00Z